IM Cannabis Corp.

Listed Company
IMCCCIK 0001792030NasdaqNon-AcceleratedEmerging GrowthMedicinal Chemicals & Botanical ProductsA1ILFY ends Dec 31
Period
FY 2025
Revenue
Net Income
$-11.75M
Total Assets
$31.74M
Equity
Shares Out
5.89M
Op. Cash Flow

Business

IM Cannabis Corp. is an international medical cannabis company that imports, distributes and sells premium cannabis products through retail pharmacies, online platforms and logistics hubs. It offers dried flowers, full-spectrum extracts and oils under IMC and other premium brands, and provides repackaging and EU‑GMP production services. Key segments are Israeli retail/distribution (IMC Holdings, Pharm Yarok), German operations via Adjupharm and logistics, and brand sourcing/licensing. The company serves patients in Israel and Germany through pharmacies, home delivery and online channels, leveraging international suppliers.

Summary from filing dated 2025-03-31

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$-11.75M
Total assets$31.74M
Total liabilities$35.35M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro